0.01
—
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Eve Health Group
Its shares trade on ASX under the ticker EVE.AX. It has been listed since 8 April 2004. In the fiscal year to 30 June 2026, it reported revenue of A$1.2m and a net loss of A$1.9m. At that date it held total assets of A$4.3m and shareholders' equity of A$3.9m.
EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-04-08. The Company’s segments include Jenbrook, Meluka and Investment. The Jenbrook segment produces organic tea tree and distributes Australian botanical oils. The Meluka segment is a retail health and wellness consumer brand. The Meluka segment provides retail health and wellness consumer products, including honey. The firm owns and operates the Robyndale organic tea tree plantation in the Bungawalbin Valley in Northern New South Wales. Jenbrook farm offers products, including essential oil, dried leaf, hydrosol, and extract. Its Naturally Australian Products is a wholesaler of native Australian essential oils. The firm offers various products, including Essential Oil blends, Botanical Raw Honey collection, Raw Honey Probiotic Concentrate Tea Tree, and others. The company operates in markets across Australia and New Zealand, Asia Pacific, and North America.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 8 Apr 2004
- Website
- evehealthgroup.com.au ↗
Leadership
Pay as last reported
- Mr. Gregory FryChief Executive Officer, Managing Director, since 2009$401,393
- Mr. Ben RohrChief Operating Officer$283,599
- Mr. Steven JacksonCompany Secretary
- Mr. Carlos JinNon-Executive Director$41,205
- Mr. James LinNon-Executive Director$7,335
- Mr. Rodney HanningtonNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jenbrook segment produces organic tea tree and distributes Australian botanical oils.
- Meluka segment provides retail health and wellness consumer products including honey.
- Robyndale organic tea tree plantation in Bungawalbin Valley supplies key ingredients.
Weaknesses
- EVE Health Group Ltd. has no international headquarters outside Subiaco, Western Australia.
- The company's segments are limited to Jenbrook, Meluka, and Investment only.
- The firm's product range is primarily focused on Australian botanicals and honey.
Opportunities
- Expansion into Asia Pacific markets with Naturally Australian Products wholesaler.
- Growth potential in North America through Meluka retail health and wellness brand.
- Increasing demand for organic products in Australia and New Zealand.
Threats
- Competition from global health and wellness brands in North America.
- Regulatory challenges in the Food Products industry in Australia.
- Dependence on Australian botanical sources for key ingredients.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.